A. Elegbe
发表论文 29 篇 · 总被引 554 次 · h-index 8
代表论文
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial (2013 · Annals of the Rheumatic Diseases · 被引 279)
- Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel‐Arm, Open‐Label Study (2013 · Arthritis care & research · 被引 72)
- Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial (2018 · Journal of Rheumatology · 被引 36)
- Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome (2017 · Kidney International Reports · 被引 24)
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis : two-year ef fi cacy and safety fi ndings from AMPLE trial (2013 · 被引 19)
- OP0253 A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class iii or iv lupus nephritis (2018 · FRIDAY, 15 JUNE 2018 · 被引 17)